Clinical trials: Lymph Node Neoplasm
Anemia, Cancer Fatigue
Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia
This phase II trial studies the side effects of ex vivo-activated autologous lymph node lymphocytes infusion and to see how well they work in treating patients with chronic lymphocytic leukemia.
- Conditions
- Anemia, Cancer Fatigue, Chronic Lymphocytic Leukemia, Fever
- Trial name
- NCT02530515
- Testing
- Ex Vivo-activated Autologous Lymph Node Lymphocytes, Laboratory Biomarker Analysis
- Where
- United States
- Volunteers
- 8 people
- Sponsor
- M.D. Anderson Cancer Center
Early-stage Breast Cancer
Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients
Primarily, this clinical investigation compared the efficacy of cyclophosphamide + methotrexate + fluorouracil chemotherapy vs. goserelin + tamoxifen treatment in terms of prognosis (disease-free survival, overall survival) in…
- Trial name
- NCT00309478
- Testing
- Cyclophosphamide, Methotrexate, Fluorouracil implant
- Volunteers
- 1,099 people
- Sponsor
- Austrian Breast & Colorectal Cancer Study Group
Breast Cancer
Predictive Model of Axillary Nodal Status After Neoadjuvant Chemotherapy in Breast Cancer Patients
The management of patients diagnosed with breast cancer (BC) with axillary nodal involvement is still a controversial topic. These patients' treatment usually involves the administration of a neoadjuvant chemotherapy (NAC) in…
- Trial name
- LNNEO (NCT05798806)
- Where
- Italy
- Volunteers
- 1,950 people
- Sponsor
- Istituti Clinici Scientifici Maugeri SpA
Esophageal Squamous Cell Carcinoma
Immunotherapy Plus Anlotinib After Surgery for Esophageal Squamous Cell Cancer With Residual Tumor and Positive Lymph Nodes
The goal of this clinical trial is to learn whether postoperative immunotherapy combined with anlotinib can help prevent or delay cancer recurrence in adults aged 18 to 75 years with locally advanced esophageal squamous cell…
- Trial name
- NCT07830355
- Testing
- Anlotinib, Anti-PD-1 Monoclonal Antibody
- Volunteers
- 75 people
- Sponsor
- Shanghai Chest Hospital
Central Nervous System Neoplasms, Central Nervous System Tumor
Mapping Draining Lymph Nodes in CNS Malignancies
The purpose of this research study is to determine whether the lymph nodes that drain a brain tumor can be detected by imaging after injection of a substance called Tc-99m tilmanocept directly into the brain tissue around the…
- Trial name
- NCT04096716
- Testing
- Tc-99m tilmanocept
- Where
- United States
- Volunteers
- 14 people
- Sponsor
- Washington University School of Medicine
HER2 Positive Early Breast Cancer
EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer
compare the efficacy and safety of TCbHP and EC-THP regimen in HER2-positive breast cancer patients
- Trial name
- NCT05883852
- Testing
- Docetaxel, carboplatin, Trastuzumab
- Where
- China
- Volunteers
- 1,406 people
- Sponsor
- Fudan University
Endometrium Cancer
Endometrial Cancer and Robotic-assisted Versus Traditional Laparoscopy
The aim of this study is to compare the robotic-assisted laparoscopic surgery to the traditional laparoscopic surgery in endometrial cancer patients.
- Trial name
- NCT01466777
- Testing
- Traditional surgery type, Robotic assisted laparoscopic surgery
- Where
- Finland
- Volunteers
- 100 people
- Sponsor
- Tampere University Hospital
Breast Cancer, Mastectomy
Effect of Dexmedetomidine on the Duration of Pain Control in ESP Block for Breast Surgery
Patients undergoing Partial or total mastectomy with axillary LN dissection will receive prior to induction of general anaesthesia ESP block at T4 level at the same side of the surgery.
- Conditions
- Breast Cancer, Mastectomy, Axillary Lymph Node Dissection, Pain, Postoperative
- Trial name
- NCT04029467
- Testing
- Dexmedetomidine
- Where
- Lebanon
- Volunteers
- 44 people
- Sponsor
- Lebanese American University
Breast Cancer
Docetaxel in Breast Cancer
Primary objective : To compare disease-free survival after treatment with docetaxel in combination with doxorubicin and cyclophosphamide to doxorubicin and cyclophosphamide followed by docetaxel in operable adjuvant breast cancer…
- Trial name
- NCT00312208
- Testing
- docetaxel, doxorubicin, cyclophosphamide, Docetaxel,doxorubicin, cyclophosphamide
- Where
- 37 sites in United States, Argentina and 35 more
- Volunteers
- 3,299 people
- Sponsor
- Sanofi
Bladder Cancer
Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-Eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)
The purpose of this study is to assess the antitumor efficacy and safety of perioperative enfortumab vedotin (EV) plus pembrolizumab and radical cystectomy (RC) + pelvic lymph node dissection (PLND) compared with the current…
- Trial name
- KEYNOTE-B15 (NCT04700124)
- Testing
- Pembrolizumab, Enfortumab vedotin (EV), RC + PLND
- Where
- 188 sites in United States, Argentina and 27 more
- Volunteers
- 808 people
- Sponsor
- Merck Sharp & Dohme LLC
Breast Cancer
Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which regimen of chemotherapy is more effective for breast cancer.
- Trial name
- NCT00004125
- Testing
- cyclophosphamide, docetaxel, doxorubicin hydrochloride
- Where
- 48 sites in United States
- Sponsor
- Eastern Cooperative Oncology Group
Sentinel Lymph Node, Colorectal Cancer
Sentinel Lymph Node (SLN) in Colorectal Carcinoma (CRC) With a Near-infrared (NIR)-Dye
The sentinel lymph node (SLN) procedure is a standard staging technique in several types of cancer. One of the major problems of SLN mapping in colorectal cancer is the lack of an optimal dye and technique for identification of…
- Conditions
- Sentinel Lymph Node, Colorectal Cancer, Metastasis
- Trial name
- NCT02122523
- Testing
- Near-Infrared (NIR) dye Indocyanin Green (ICG)
- Where
- Netherlands
- Volunteers
- 25 people
- Sponsor
- Amsterdam UMC, location VUmc
Locally Advanced Malignant Neoplasm, Inflammatory Breast Carcinoma
Olaparib and Radiotherapy in Inoperable Breast Cancer
The majority of breast cancer patients receive radiotherapy as part of their treatment. Radiotherapy improves both locoregional control and overall survival.
- Conditions
- Locally Advanced Malignant Neoplasm, Inflammatory Breast Carcinoma, Triple-Negative Invasive Breast Carcinoma
- Trial name
- NCT02227082
- Testing
- radiotherapy, olaparib
- Where
- Netherlands
- Volunteers
- 7 people
- Sponsor
- The Netherlands Cancer Institute
Vulvar Cancer
A Non-Randomized Study to Evaluate Leg Lymphatic Drainage Associated With Surgical Intervention for Vulvar Cancer
This will be a non-blinded, non-randomized study to further our knowledge of and experience with lymph node surgery. The investigators are interested in documenting and reporting the variations in leg lymphatic drainage sentinel…
- Trial name
- NCT01321697
- Testing
- Routine Leg edema and groin dissection
- Where
- United States
- Volunteers
- 7 people
- Sponsor
- University of Arkansas
Sentinel Lymph Node, Breast Cancer
Sentinel Lymph Node Biopsy in Breast Cancer Surgery Using ICG
This clinical trial is a prospective, multicenter, self-controlled clinical study. In order to meet the requirements of this plan, 130 breast cancer patients need the sentinel lymph node biopsy with novel near-infarred…
- Trial name
- NCT03579979
- Testing
- Methylene Blue, Indocyanine Green
- Where
- China
- Volunteers
- 130 people
- Sponsor
- Chinese Academy of Sciences
Early Stage Endometrial Cancer, Sentinel Lymph Nodes
Sentinel Lymph Node Biopsy Versus Lymphadenectomy in Endometrial Cancer
To compare sentinel lymph nodes biopsy versus comprehensive lymphadenectomy in patients with early stage endometrial cancer.
- Conditions
- Early Stage Endometrial Cancer, Sentinel Lymph Nodes, Lymphadenectomy
- Trial name
- NCT05048173
- Testing
- Sentinel lymph node mapping and biopsy, Lymphadenectomy
- Where
- Taiwan
- Volunteers
- 334 people
- Sponsor
- Far Eastern Memorial Hospital
Vulvar Cancer, Sentinel Lymph Node
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
Vulvar cancer patients with SN-metastasis > 2mm will receive chemoradiation instead of an inguinofemoral lymphadenectomy.
- Conditions
- Vulvar Cancer, Sentinel Lymph Node, Lymph Node Metastases
- Trial name
- GROINSS-VIII (NCT05076942)
- Testing
- Radiotherapy combined with cisplatin, Cisplatin
- Where
- 27 sites in United States, Netherlands
- Volunteers
- 157 people
- Sponsor
- University Medical Center Groningen
Gastric Cancer, Sentinel Lymph Node
Gastric Cancer Sentinel Lymph Node Mapping
Gastric cancer has an incidence in North America of over 24,000 new cases annually, of which approximately 15% are diagnosed at an early stage.
- Conditions
- Gastric Cancer, Sentinel Lymph Node, Early Gastric Cancer
- Trial name
- NCT03049345
- Testing
- Sentinel Lymph Node Sampling, Radioactive Tracers, Methylene Blue 20 MG/ML
- Where
- Canada
- Volunteers
- 40 people
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
Breast Cancer
Correlation Between Fluorodeoxyglucose (FDG) and FLT Uptake and Gene-Expression Oncotype Assay in Patients With Breast Cancer
In the current study FDG (Fluorodeoxyglucose) uptake, FLT uptake (F18-Fluoro-3'-deoxythymidine) and their ratios will be correlated with the risk score results of the Oncotype gene-expression assay in patients with clinically…
- Trial name
- NCT00688337
- Where
- Israel
- Volunteers
- 100 people
- Sponsor
- Tel-Aviv Sourasky Medical Center
Breast Cancer
Technetium Tc 99m Sulfur Colloid and Blue Dye In Detecting Sentinel Lymph Nodes in Patients With Breast Cancer
RATIONALE: It is not yet known whether injecting technetium Tc 99m sulfur colloid and blue dye near the tumor is more effective than injecting them near the nipple in identifying sentinel lymph nodes in patients with stage I or…
- Trial name
- NCT00052676
- Testing
- patent blue V dye, radionuclide imaging, sentinel lymph node biopsy
- Where
- 7 sites in France
- Sponsor
- Centre Paul Strauss
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.